Variable expression of familial Alzheimer disease associated with presenilin 2 mutation M239I
- 23 May 2000
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 54 (10) , 2006-2008
- https://doi.org/10.1212/wnl.54.10.2006
Abstract
Article abstract In a family with autopsy-confirmed Alzheimer disease, the authors found a mutation in the presenilin 2 (PS2) gene (PSEN2) that predicts a methionine-to-isoleucine change at PS2 residue 239 (M239I), at which a change to valine was known in another family. Phenotypic expression of M239I was highly variable, with disease onset between age 44 and 58 years, and two nonaffected mutation carriers at age 58 and 68 years. The data showed no influence of APOE but were compatible with other possible genetic modifiers of the phenotype or penetrance of M239I.Keywords
This publication has 9 references indexed in Scilit:
- Polymorphism of the prion protein is associated with cognitive impairment in the elderlyNeurology, 1998
- Two novel (M233T and ρ278T) presenilin-1 mutations in early-onset Alzheimerʼs disease pedigrees and preliminary evidence for association of presenilin-1 mutations with a novel phenotypeNeuroReport, 1997
- Wide range in age of onset for chromosome 1‐related familial Alzheimer's diseaseAnnals of Neurology, 1996
- Alzheimer's disease associated with mutations in presenilin 2 is rare and variably penetrantHuman Molecular Genetics, 1996
- Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 geneNature, 1995
- Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's diseaseNeurology, 1993
- Fatal Familial Insomnia and Familial Creutzfeldt-Jakob Disease: Disease Phenotype Determined by a DNA PolymorphismScience, 1992
- The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)Neurology, 1991
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984